Keita Mori is the founder of SanBio. SanBio has raised $24M in total funding. Latest round: IPO. Backed by Biotech-Healthcare Partners, NIF ventures.
Keita Mori is the Co-CEO and Founder of SanBio, a biotechnology company established in 2001 focused on cell therapy for neurological disorders including stroke, traumatic brain injuries, eye diseases, and Parkinson's disease. He led SanBio's initial fundraising efforts, securing Series A ($3M), Series B ($1M), and Series C ($20M) financing from Japanese bio-related VCs before the company went public on MOTHERS in April 2015. Mori works in the biotechnology industry and is based in the biotechnology sector.
Full founder directory · Investor directory · Company funding database · Fundraising library